KARLA PRAY: Open Payments
NPI 1801153531 · GLOUCESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,376 in 35 payments from 23 companies in 2025. Trend: 2023 $550 · 2024 $631 · 2025 $1,376
Food & beverage: $1,178Education: $198
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 2 | $188 |
| Mirum Pharmaceuticals, Inc. | 1 | $165 |
| Janssen Biotech, Inc. | 2 | $134 |
| Eisai Inc. | 2 | $116 |
| SEAGEN INC. | 1 | $99 |
| Novartis Pharmaceuticals Corporation | 3 | $81 |
| Merck Sharp & Dohme LLC | 3 | $69 |
| AstraZeneca Pharmaceuticals LP | 2 | $53 |
| Legend Biotech USA Inc. | 2 | $51 |
| SERVIER PHARMACEUTICALS LLC | 2 | $50 |
Products named: Livmarli, RYBREVANT, IQIRVO, Onivyde, LYNPARZA, CARVYKTI, Tibsovo, KISQALI.
Industry payments across VA — which companies pay providers there.
